Study: Katie Couric wakes up America on colonoscopy screening

May 03, 2002

U-M study demonstrates the effect that celebrity spokespeople can have on public behavior.

ATLANTA - She's known as the perky co-host of NBC's "Today Show", and millions of Americans wake up to her every morning. And each morning, Katie Couric's faithful viewers depend on her to not only deliver the news but also to keep them informed on the latest in home life, fashion sense, and health care. So it's no surprise when Katie does something, much of America does too.

Evidence of this was obvious in March of 2000, when Couric underwent a live, on-air colonoscopy on the "Today Show", two years after the tragic death of her husband Jay Monahan from colon cancer at age 42. This was the cornerstone of a week-long series the show ran promoting colon cancer awareness and endorsing colorectal cancer screening.

In the months following the broadcast, interest in colon cancer prevention increased dramatically, but the actual effect on colon cancer screening was not quantified. Today, researchers from the University of Michigan Health System at the Society of General Internal Medicine meeting in Atlanta reported that Couric's campaign did have a substantial effect on the number of cancer screening tests. They call this finding the "Couric Effect".

"Our study found Ms. Couric's campaign resulted in a substantial increase in colonoscopies performed across the country," says Mark Fendrick, M.D., senior author on the paper and co-director of the Consortium for Health Outcomes, Innovation, Cost Effectiveness Studies or CHOICES at UMHS. "Not only did Ms. Couric's television campaign have an immediate impact, but the significant increase in screening rates remained long after the broadcast."

Using a population-based observational study, the U-M researchers examined colonoscopy rates drawn from a database of 400 endoscopists nationwide, as well as rates from a Midwestern managed care organization from July 1998 (89 weeks before Ms. Couric's procedure) through December 2000 (40 weeks after). Peter Cram, M.D., lead author on the study and an internal medicine lecturer at UMHS, says the results were striking.

"Our study shows the number of colonoscopies increased by 19 percent, and was sustained for 40 weeks," says Cram. "Colorectal cancer is the second leading cause of cancer death among Americans. It is important to point out that a majority of these deaths can be prevented if people underwent the recommended screening. So the fact that Ms. Couric's campaign demonstrated nearly a 20 percent increase in the number of screenings is an exciting finding."

The study also revealed that significantly more women and younger individuals underwent colonoscopy following Ms. Couric's campaign than before, a finding consistent with the demographics of the "Today Show" viewers, who are 60 percent female with a median age of 47.5.

Fendrick says this study suggests a celebrity spokesperson - even one who doesn't suffer from the disease they are promoting - can have a dramatic impact on public behavior related to that disease. Although Fendrick views Couric's campaign as a tremendous success, he says there are many more people at risk for colon cancer that still should undergo colon cancer screening.

"There's no question Ms. Couric had a direct impact on the increase in colonoscopy screenings across the country," Fendrick says. "Despite the overwhelming evidence that colon cancer screening saves lives, half of Americans who could benefit from screening are not getting it. We need more celebrity spokespeople like Katie Couric to help get the word out."
-end-
The other authors on the study are Sandeep Vijan, M.D., M.S., John Inadomi, M.D., Mark E. Cowen, M.D., S.M., Daniel Carpenter, Ph.D., all from UMHS.

University of Michigan Health System

Related Colorectal Cancer Articles from Brightsurf:

Colorectal cancer treatment: the winning combinations
Chemotherapy has distressing side effects for patients and increases the risk of developing resistance to the treatment.

A new model to predict survival in colorectal cancer
This signature could be useful in clinical practice, especially for colorectal cancer diagnosis and therapy.

Roadmap to reducing colorectal cancer deaths
The American Gastroenterological Association has outlined a strategy to increase the number of people screened via tests that are more convenient, accurate and less expensive and tailored to people's individual cancer risks.

Study provides new insight on colorectal cancer growth
A new study by researchers at the University of Kentucky identifies a novel function of the enzyme spermine synthase to facilitate colorectal cancer growth.

Researchers ID target for colorectal cancer immunotherapy
Researchers at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center have identified a target for colorectal cancer immunotherapy.

Colorectal cancer partner-in-crime identified
A protein that helps colorectal cancer cells spread to other parts of the body could be an effective treatment target.

Cancer cell reversion may offer a new approach to colorectal cancer treatment
A novel approach to reverse the progression of healthy cells to malignant ones may offer a more effective way to eradicate colorectal cancer cells with far fewer side effects, according to a KAIST research team based in South Korea.

A novel pathway to target colorectal cancer
Survival rates for patients with late-stage colorectal cancer are dismal, and new therapeutic strategies are needed to improve outcomes.

Colorectal cancer rates in Canada
The incidence of colorectal cancer among younger adults increased in recent years in this analysis of data from Canadian national cancer registries that included about 688,000 new colorectal cancers diagnosed over more than 40 years.

Cancer drugs promote stem cell properties of colorectal cancer
Scientists from the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) and the Mannheim University Medical Center have now discovered that a certain group of cancer drugs (MEK Inhibitors) activates the cancer-promoting Wnt signalling pathway in colorectal cancer cells.

Read More: Colorectal Cancer News and Colorectal Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.